functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />
to follow the use of HBOT in these ‚nontraditional‛<br />
conditions. This chapter is not designed<br />
to outline the established uses of hyperbaric<br />
<strong>medicine</strong>, which are well published <strong>and</strong><br />
documented. Rather, the purpose is to review the<br />
current literature regarding the use of HBOT for<br />
the treatment of three of our most challenging<br />
conditions: multiple sclerosis, autism, <strong>and</strong> traumatic<br />
brain injury.<br />
Multiple Sclerosis<br />
Clinical Vignette<br />
RW, a 56 year old married white female, began<br />
to have atypical headache approximately 25 years<br />
ago. She presented repeatedly to her primary care<br />
physician over the course of 10 years with<br />
complaint of head <strong>and</strong> neurological changes. Her<br />
husb<strong>and</strong>, an internal <strong>medicine</strong> specialist, sought<br />
expert opinion from a local university with a<br />
specialty head pain clinic. She was given a<br />
diagnosis of ‚complex migraine stroke‛ after having<br />
normal brain studies <strong>and</strong> neurological examinations.<br />
She continuedto experience atypical migraine<br />
headache with subsequent temporary loss of vision<br />
<strong>and</strong> motor function. After approximately 10 years,<br />
she was diagnosed by MRI with relapsing-remitting<br />
multiple sclerosis, based on typical periventricular<br />
white matter changes. Further studies such as<br />
spinal fluid analysis for oligoclonal b<strong>and</strong>ing was<br />
notpursued. She has been treated with a variety<br />
of interferon medications <strong>and</strong> is currently taking<br />
interferon-beta (Rebif), muscle relaxors <strong>and</strong> an<br />
antidepressant. Neuropathic pain is managed with<br />
a Fentanyl patch every 72 hours. Physical exam<br />
findings include obesity <strong>and</strong> right lower extremity<br />
weakness, particularly quadraceps weakness,<br />
necessitating the use of a cane for assistance with<br />
ambulation. The patient’s husb<strong>and</strong> admits to<br />
concerns with her ability to reason <strong>and</strong> emotional<br />
lability. Neuropsychological assessment has not<br />
been performed (Beck Depression Inventory,<br />
Modified Boston Naming Test, MMSE,<br />
Constructional Praxis, <strong>and</strong> Word List Memory as<br />
examples.)<br />
Review of the Literature <strong>and</strong> Discussion<br />
141<br />
Multiple sclerosis (MS), a disease of unknown<br />
etiology, is the ‚most common autoimmune<br />
inflammatory demyelinating disease of the central<br />
nervous system.‛ (5) It is characterized by<br />
inflammation of the central nervous system leading<br />
to nerve demyelination. Ultimately, axon<br />
degeneration leads to clinical manifestations, such<br />
as weakness of extremities, numbness, <strong>and</strong><br />
psychological changes. (6) MS is most commonly<br />
know to affect women of childbearing age of<br />
Northern European lineage, with Northern Irel<strong>and</strong><br />
having the highest per capital population of MS<br />
patients.(7)<br />
The differential diagnosis of MS is fairly broad <strong>and</strong><br />
includes genetic <strong>and</strong> congenital CNS<br />
diseases, inflammatory diseases such as<br />
polyarteritis nodosa, systemic lupus erythematosus<br />
(SLE), Behçet’s disease, Sjögren's disease,<br />
retroviral illness, <strong>and</strong> syphilis. Many of these<br />
conditions can cause similar MRI changes <strong>and</strong><br />
manifest with peculiar neurological symptoms.(8)<br />
The current st<strong>and</strong>ard for diagnosis is the<br />
McDonald criteria. The principle of diagnosis rests<br />
with establishing a pattern of clinical findings <strong>and</strong><br />
MRI changes across both space (different areas<br />
of the CNS) <strong>and</strong> time (symptoms <strong>and</strong> lesions are<br />
evolving). Clinical findings suggestive of the<br />
disease include age of onset between 15 <strong>and</strong> 50<br />
years, a relapsing remitting pattern of neurological<br />
change, optic nerve involvement, <strong>and</strong> fatigue.<br />
The diagnosis does not rely upon laboratory<br />
evidence of the disease.(9) The pathophysiology<br />
of MS revolves around the concept of CNS<br />
vascular inflammation causing disruption of the<br />
blood brain barrier leading to an autoimmune<br />
assault involving the myelin sheaths. This repetitive<br />
demyelination ultimately leads to permanent<br />
neurologic damage <strong>and</strong> subsequent clinical<br />
symptoms.(10)<br />
The cornerstone treatment of MS involves immune<br />
modifying interferon beta-1b (Betaseron) <strong>and</strong><br />
beta-1a (Avalox), <strong>and</strong> glatiramer acetate<br />
(Copaxone). Other treatments focus on relieving<br />
symptoms <strong>and</strong> improving quality of life through the<br />
use ofphysical therapy, occupational therapy, anti-<br />
2012